167 Toxina Botulinica - Antonio Rondón Lugo

glabellar lines: a double-blind, randomized study. J Am AcadDermatol. 2006;55:975-8019. Nettar K, Yu K, Bapna J, Maas C. An internallycontrolled, doublé-blind comparasion of the efficacy ofOnabotulinumtoxinA and AbobotulinumtoxinA. Arch FacialPlast Surg. 2011;13:380-620. Sattler G, Callander M, Grablowitz D, Walker T, Bee EK,Rzany B, et al. Noninferiority of incobotulinumtoxinA, free froncomplexing proteins, compared with another botulinum toxintpe A in the treatment of glabellar frown lines. Dermatol Surg.2010;36:2146-5421. Stengel G, Bee EK. Antibody- induced secondarytreatment failure in a patient treated with botulinum toxin typeA for glabellar frown lines. Clin Interv Aging. 2011; 6:281-422. Brandt F, O`Connell C, Cazzaniga A., Waugh JM.Efficacy and safety evaluation of a novel botulinum toxintopical gel for the treatment of moderate to severe lateralcanthal lines. Dermatol Surg. 2010;36(Suppl. 4):2111-823. Glogau RG, Topically applied botulinum toxin type A forthe treatment of primary axillary hiperhidrosis: results of arandomized, blinded, vehicle-controlled study. Dermatol Surg.2007;33:S76-8024. Yeh FL, Zhu Y, Tepp WH, Johnson EA, Bertics PJ,Chapman ER: Retargeted clostridial neurotoxins as novelagents for treating chronic diseases. Biochemistry. 2011;50:10419-2125. Klein AW: “Dilution and storage of Botulinumtoxin”.Dermatol Surg. 1998;11:117926. Ascher B, Talaico S, Cassuto D, Escobar S, Hexsel D,Jaén P, et al. International consensus recommendations onthe aesthetic usage of botulinum toxin type A (SpewwoodUnit)-part II: wrinkles on the middle and lower face, neck andchest. J Eur Acad Dermatol Venereol. 2010;24:1285-9527. Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol.2010;55:8-1428. Smith KC. Botulinum toxin type A: New informationabout an old medicine. Skin Therapy Lett. 2011;16:3-629. Saenz JW, Sams RW, Jamieson B. FPIN`s clinicalinquiries. Treatment of hyperhidrosis. Am Fam Physician.2011;83:465-630. Smith L, Polsky D, Franks Jr A. Botulinum toxin A for thetreatment of Raynaud syndrome. Arch Dermatol2012;148:426-28